Overview
You can access the company’s website by clicking here.
Fundamentals
Price
News
-
02 Mar 2021 2 min read
QuotedData’s morning briefing 2 March 2021
In QuotedData’s morning briefing 2 March 2021: Syncona (SYNC) notes that Achilles Therapeutics, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumours, announced it has filed a registration statement in relation to a proposed IPO. Syncona owns 44% of Achilles which it values at £72.4m. RTW Venture Fund (RTW) participated in a Series […]
-
15 Dec 2016 2 min read
Chelverton Small Companies Dividend Trust underperforms benchmark during first half
Chelverton Small Companies Dividend Trust has announced its interim results for the half year ended 31 October 2016. During the period, the trust’s NAV fell by 2.97%, which it says compares against a rise in its benchmark index, the MSCI UK Small Cap Index, of 6.13%. The trust paid a dividend of 3.7p per share […]
-
04 Dec 2015 3 min read
Small Companies Dividend Trust convincingly beats benchmark in H1
Small Companies Dividend Trust has announced its interim results for the six-months ended 31 October 2015. During the period, the NAV per ordinary share rose 11.6% beating the MSCI Small Cap Index, which fell 2.02%. The ordinary share price increased by 17.1% during the period and the discount narrowed from 16.99% to 12.90%. A second […]
